Related references
Note: Only part of the references are listed.Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)
Matthias Schiedel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The Current State of NAD(+)-Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets
Matthias Schiedel et al.
MEDICINAL RESEARCH REVIEWS (2018)
SIRT7 Is an RNA-Activated Protein Lysine Deacylase
Zhen Tong et al.
ACS CHEMICAL BIOLOGY (2017)
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis
Shenzhen Huang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket
Sandeep Sundriyal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease
Rita Machado de Oliveira et al.
PLOS BIOLOGY (2017)
Sirtuin 2 Regulates Microvascular Inflammation during Sepsis
Nancy Buechler et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Comprehensive characterization of the Published Kinase Inhibitor Set
Jonathan M. Elkins et al.
NATURE BIOTECHNOLOGY (2016)
SIRT7 Is Activated by DNA and Deacetylates Histone H3 in the Chromatin Context
Zhen Tong et al.
ACS CHEMICAL BIOLOGY (2016)
Structure-Based Development of an Affinity Probe for Sirtuin2
Matthias Schiedel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay: Substrate Screening and Inhibitor Evaluation
Iacopo Galleano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study
Matthias Schiedel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3
Ying-Ling Chiang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Kinetic and Structural Basis for Acyl-Group Selectivity and NAD+ Dependence in Sirtuin-Catalyzed Deacylation
Jessica L. Feldman et al.
BIOCHEMISTRY (2015)
Selective Inhibition of SIRT2 Improves Outcomes in a Lethal Septic Model
T. Zhao et al.
CURRENT MOLECULAR MEDICINE (2015)
A Novel Continuous Assay for the Deacylase Sirtuin 5 and Other Deacetylases
Claudia Roessler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
KDAC8 substrate specificity quantified by a biologically relevant, label-free deacetylation assay
Tasha B. Toro et al.
PROTEIN SCIENCE (2015)
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
Tobias Rumpf et al.
NATURE COMMUNICATIONS (2015)
Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking
Tobias Rumpf et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2015)
The Discovery of a Highly Selective 5,6,7,8-Tetrahydrobenzo[4,5]thieno[ 2,3-d] pyrimidin-4(3H)-one SIRT2 Inhibitor that is Neuroprotective in an in vitro Parkinson's Disease Model
Paolo Di Fruscia et al.
CHEMMEDCHEM (2015)
Efficient Demyristoylase Activity of SIRT2 Revealed by Kinetic and Structural Studies
Yan-Bin Teng et al.
SCIENTIFIC REPORTS (2015)
Fluorescence-Based Screening Assays for the NAD(+)-Dependent Histone Deacetylase smSirt2 from Schistosoma mansoni
Matthias Schiedel et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
KDAC8 substrate specificity quantified by a biologically relevant, label-free deacetylation assay
Tasha B. Toro et al.
PROTEIN SCIENCE (2015)
Lysine Glutarylation Is a Protein Posttranslational Modification Regulated by SIRT5
Minjia Tan et al.
CELL METABOLISM (2014)
SIRT2 induces the checkpoint kinase BubR1 to increase lifespan
Brian J. North et al.
EMBO JOURNAL (2014)
A Novel Sirtuin 2 ( SIRT2) Inhibitor with p53-dependent Pro- apoptotic Activity in Non- small Cell Lung Cancer*
Gesine Hoffmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach
Huaqing Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Chroman-4-one- and Chromone-Based Sirtuin 2 Inhibitors with Antiproliferative Properties in Cancer Cells
Tina Seifert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Mechanism of Inhibition of the Human Sirtuin Enzyme SIRT3 by Nicotinamide: Computational and Experimental Studies
Xiangying Guan et al.
PLOS ONE (2014)
Chromo-pharmacophores: photochromic diarylmaleimide inhibitors for sirtuins
C. Falenczyk et al.
CHEMICAL SCIENCE (2014)
Identification of 'erasers' for lysine crotonylated histone marks using a chemical proteomics approach
Xiucong Bao et al.
ELIFE (2014)
The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation
Teresa Faria Pais et al.
EMBO JOURNAL (2013)
SIRT1 and SIRT2: emerging targets in neurodegeneration
Gizem Donmez et al.
EMBO MOLECULAR MEDICINE (2013)
Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins
Jessica L. Feldman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
HDAC6 and SIRT2 Regulate the Acetylation State and Oncogenic Activity of Mutant K-RAS
Moon Hee Yang et al.
MOLECULAR CANCER RESEARCH (2013)
SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine
Hong Jiang et al.
NATURE (2013)
Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism
Melanie Gertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Role for SIRT2-Dependent Histone H3K18 Deacetylation in Bacterial Infection
Haig A. Eskandarian et al.
SCIENCE (2013)
Profiling of Substrates for Zinc-dependent Lysine Deacylase Enzymes: HDAC3 Exhibits Decrotonylase Activity In Vitro
Andreas S. Madsen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
NAD+-dependent Sirtuin 1 and 6 Proteins Coordinate a Switch from Glucose to Fatty Acid Oxidation during the Acute Inflammatory Response
Tie Fu Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors
Takayoshi Suzuki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Substrates for Efficient Fluorometric Screening Employing the NAD-Dependent Sirtuin 5 Lysine Deacylase (KDAC) Enzyme
Andreas S. Madsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo
Anna Bobrowska et al.
PLOS ONE (2012)
The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington's Disease Mouse Models
Vanita Chopra et al.
CELL REPORTS (2012)
SIRT2 as a therapeutic target for age-related disorders
Rita Machado de Oliveira et al.
FRONTIERS IN PHARMACOLOGY (2012)
A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase
David M. Taylor et al.
ACS CHEMICAL BIOLOGY (2011)
SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
Hyun-Seok Kim et al.
CANCER CELL (2011)
Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling
Bogdan Beirowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Jintang Du et al.
SCIENCE (2011)
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Barrie Peck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
NAD+-Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets
Joerg Schemies et al.
MEDICINAL RESEARCH REVIEWS (2010)
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
Ruth Luthi-Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling
Eric Verdin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity
Dirk Beher et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
E. Lara et al.
ONCOGENE (2009)
Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3
Lei Jin et al.
PROTEIN SCIENCE (2009)
Transcriptional targets of sirtuins in the coordination of mammalian physiology
Jerome N. Feige et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Mammalian sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation
David B. Lombard et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease
Tiago Fleming Outeiro et al.
SCIENCE (2007)
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition
Johannes Trapp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction
Marcia C. Haigis et al.
GENES & DEVELOPMENT (2006)
Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1
AD Napper et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
In vitro assays for the determination of histone deacetylase activity
B Heltweg et al.
METHODS (2005)
Mechanism of human SIRT1 activation by resveratrol
MT Borra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Substrate-specific activation of sirtuins by resveratrol
M Kaeberlein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Polytriazoles as copper(I)-stabilizing ligands in catalysis
TR Chan et al.
ORGANIC LETTERS (2004)
Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase
F Yeung et al.
EMBO JOURNAL (2004)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase
BJ North et al.
MOLECULAR CELL (2003)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
Share Paper
